12:00 AM
May 19, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Enablex: CTA accepted

In 1H09, BMP Sunstone Corp. (NASDAQ:BJGP, Plymouth Meeting, Pa.) plans to start a Chinese trial of Enablex darifenacin. The company...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >